Organon & Co.
(NYSE) OGN
Organon & Co. Financials at a Glance
Market Cap
$2.22B
Revenue (TTM)
$6.22B
Net Income (TTM)
$187.00M
EPS (TTM)
$0.72
P/E Ratio
11.92
Dividend
$0.08
Beta (Volatility)
0.89 (Low)
Dividend
$0.08
Beta (Volatility)
0.89 (Low)
Price
$8.52
Volume
554,910
Open
$8.60
Price
$8.52
Volume
554,910
Open
$8.60
Previous Close
$8.52
Daily Range
$8.12 - $8.94
52-Week Range
$5.69 - $13.24
Dividend
$0.08
Beta (Volatility)
0.89 (Low)
Price
$8.52
Volume
554,910
Open
$8.60
Previous Close
$8.52
Daily Range
$8.12 - $8.94
52-Week Range
$5.69 - $13.24
OGN News
OGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Organon & Co.
Industry
Pharmaceuticals
Sector
Health CareEmployees
10,000
CEO
Joseph T. Morrissey, Jr., MBA
Website
www.organon.comHeadquarters
Jersey City, NJ 07302, US
OGN Financials
Key Financial Metrics (TTM)
Gross Margin
54%
Operating Margin
20%
Net Income Margin
3%
Return on Equity
31%
Return on Capital
12%
Return on Assets
1%
Earnings Yield
8.39%
Dividend Yield
0.01%
Payout Ratio
47.06%
Stock Overview
Market Cap
$2.22B
Shares Outstanding
260.32M
Volume
554.91K
Short Interest
0.00%
Avg. Volume
5.45M
Financials (TTM)
Gross Profit
$3.36B
Operating Income
$1.28B
EBITDA
$1.28B
Operating Cash Flow
$700.00M
Capital Expenditure
$162.00M
Free Cash Flow
$538.00M
Cash & ST Invst.
$574.00M
Total Debt
$8.80B
Organon & Co. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.51B
-5.3%
Gross Profit
$759.00M
-15.3%
Gross Margin
50.36%
N/A
Market Cap
$2.22B
N/A
Market Cap/Employee
$222.31K
N/A
Employees
10,000
N/A
Net Income
$205.00M
-288.1%
EBITDA
$65.00M
-80.9%
Quarterly Fundamentals
Net Cash
$8.23B
+1.6%
Accounts Receivable
$1.43B
-3.9%
Inventory
$0.00
-100.0%
Long Term Debt
$8.76B
-2.4%
Short Term Debt
$56.00M
-12.5%
Return on Assets
1.45%
N/A
Return on Invested Capital
11.87%
N/A
Free Cash Flow
$96.00M
-62.8%
Operating Cash Flow
$141.00M
-63.8%